Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.50
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.01
(
0.36%
)
Bitcoin
75,847.25
(
-0.06%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 258
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: To infinity and beyond! post# 211800

Sunday, 01/07/2018 3:36:20 AM

Sunday, January 07, 2018 3:36:20 AM

Post# of 405181
Kevetrin will be monetized long before 2020. The OM primary outcomes, MOA, were successful in demonstrating K’s impact on p53. IPIX won’t take on the cost burden of developing K alone.

...and the kevetrin science is on a far horizon- let's guess, 2020 before there is a trial starting to say yes or no if it actually has ANY benefit, and 2022 before results?


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote